Laura Maarit Pikkupeura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Maarit Pikkupeura has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Grzegorz J. Maciag
BRIC - Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen N DK-2200, Denmark
2 shared publications - Hjalte List Larsen
BRIC - Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen N DK-2200, Denmark
2 shared publications - Jordi Guiu
Cell Plasticity and Regeneration Group, Regenerative Medicine Program, Institut d’Investigació Biomèdica de Bellvitge–IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
2 shared publications - Kim Bak Jensen
Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
2 shared publications - Stine Lind Hansen
Cell Therapy R&D, Global Research, Novo Nordisk, Måløv, Denmark
2 shared publications - Albin Sandelin
University of Copenhagen
1 shared publication
Latest Publications
- Open Access
multiomeR: a pipeline for reproducible analysis of large-scale single-nucleus Epi Multiome datasets
Summary: The 10x Genomics Epi Multiome assay measures gene expression and chromatin accessibility in the same nuclei, and studies increasingly profile many samples. Yet analysis after Cell Ranger ARC is usually assembled by hand from separate tools, which makes it slow to revise, hard to reproduce and memory-intensive for large studies. multiomeR addresses these problems with a configurable R pipeline for quality control, processing and integration of both data types, and cell-type annotation across many samples. Plain-text configuration files record every analytical choice, each step is tracked so that a change reruns only what it affects, and data stay on disk rather than in memory. Optional modules compare groups of donors, link accessible regions to the genes they may regulate, and test which cell types are enriched for genetic associations with a trait. In a benchmark on 31 public samples (375,757 nuclei), multiomeR had a shorter estimated run time than a Seurat v5.6/Signac v2 workflow (2.2 versus 5.6 h), because it runs independent steps in parallel. It also used fewer memory gigabyte-hours (87 versus 114 GB-hours), with similar total CPU time. multiomeR thus makes large multi-sample multiome studies practical to analyze, revise and extend. Availability and implementation: multiomeR is implemented in R and runs on Linux (x86-64). Pixi installs fixed versions of all required software. It is freely available under the MIT license at https://github.com/koefoeden/multiomeR . The version described here, 1.2.2, is archived at https://doi.org/10.5281/zenodo.23369832 , and the user manual is at https://koefoeden.github.io/multiomeR/ . Contact: thomas.koefoed@sund.ku.dk ; torben.hansen@sund.ku.dk Supplementary information: Supplementary data are available online.
Open AccessmultiomeR: a pipeline for reproducible analysis of large-scale single-nucleus Epi Multiome datasets
Summary: The 10x Genomics Epi Multiome assay measures gene expression and chromatin accessibility in the same nuclei, and studies increasingly profile many samples. Yet analysis after Cell Ranger ARC is usually assembled by hand from separate tools, which makes it slow to revise, hard to reproduce and memory-intensive for large studies. multiomeR addresses these problems with a configurable R pipeline for quality control, processing and integration of both data types, and cell-type annotation across many samples. Plain-text configuration files record every analytical choice, each step is tracked so that a change reruns only what it affects, and data stay on disk rather than in memory. Optional modules compare groups of donors, link accessible regions to the genes they may regulate, and test which cell types are enriched for genetic associations with a trait. In a benchmark on 31 public samples (375,757 nuclei), multiomeR had a shorter estimated run time than a Seurat v5.6/Signac v2 workflow (2.2 versus 5.6 h), because it runs independent steps in parallel. It also used fewer memory gigabyte-hours (87 versus 114 GB-hours), with similar total CPU time. multiomeR thus makes large multi-sample multiome studies practical to analyze, revise and extend. Availability and implementation: multiomeR is implemented in R and runs on Linux (x86-64). Pixi installs fixed versions of all required software. It is freely available under the MIT license at https://github.com/koefoeden/multiomeR . The version described here, 1.2.2, is archived at https://doi.org/10.5281/zenodo.23369832 , and the user manual is at https://koefoeden.github.io/multiomeR/ . Contact: thomas.koefoed@sund.ku.dk ; torben.hansen@sund.ku.dk Supplementary information: Supplementary data are available online.
- Open Access
- 14 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (28) , eadf9460
Transcriptional and epigenomic profiling identifies YAP signaling as a key regulator of intestinal epithelium maturation
During intestinal organogenesis, equipotent epithelial progenitors mature into phenotypically distinct stem cells that are responsible for lifelong maintenance of the tissue. While the morphological changes associated with the transition are well characterized, the molecular mechanisms underpinning the maturation process are not fully understood. Here, we leverage intestinal organoid cultures to profile transcriptional, chromatin accessibility, DNA methylation, and three-dimensional (3D) chromatin conformation landscapes in fetal and adult epithelial cells. We observed prominent differences in gene expression and enhancer activity, which are accompanied by local changes in 3D organization, DNA accessibility, and methylation between the two cellular states. Using integrative analyses, we identified sustained Yes-Associated Protein (YAP) transcriptional activity as a major gatekeeper of the immature fetal state. We found the YAP-associated transcriptional network to be regulated at various levels of chromatin organization and likely to be coordinated by changes in extracellular matrix composition. Together, our work highlights the value of unbiased profiling of regulatory landscapes for the identification of key mechanisms underlying tissue maturation.
- 14 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (28) , eadf9460
Open AccessTranscriptional and epigenomic profiling identifies YAP signaling as a key regulator of intestinal epithelium maturation
During intestinal organogenesis, equipotent epithelial progenitors mature into phenotypically distinct stem cells that are responsible for lifelong maintenance of the tissue. While the morphological changes associated with the transition are well characterized, the molecular mechanisms underpinning the maturation process are not fully understood. Here, we leverage intestinal organoid cultures to profile transcriptional, chromatin accessibility, DNA methylation, and three-dimensional (3D) chromatin conformation landscapes in fetal and adult epithelial cells. We observed prominent differences in gene expression and enhancer activity, which are accompanied by local changes in 3D organization, DNA accessibility, and methylation between the two cellular states. Using integrative analyses, we identified sustained Yes-Associated Protein (YAP) transcriptional activity as a major gatekeeper of the immature fetal state. We found the YAP-associated transcriptional network to be regulated at various levels of chromatin organization and likely to be coordinated by changes in extracellular matrix composition. Together, our work highlights the value of unbiased profiling of regulatory landscapes for the identification of key mechanisms underlying tissue maturation.
- Open Access
- 14 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (28) , eadg4055
An organoid-based CRISPR-Cas9 screen for regulators of intestinal epithelial maturation and cell fate
Generation of functionally mature organs requires exquisite control of transcriptional programs governing cell state transitions during development. Despite advances in understanding the behavior of adult intestinal stem cells and their progeny, the transcriptional regulators that control the emergence of the mature intestinal phenotype remain largely unknown. Using mouse fetal and adult small intestinal organoids, we uncover transcriptional differences between the fetal and adult state and identify rare adult-like cells present in fetal organoids. This suggests that fetal organoids have an inherent potential to mature, which is locked by a regulatory program. By implementing a CRISPR-Cas9 screen targeting transcriptional regulators expressed in fetal organoids, we establishSmarca4andSmarcc1as important factors safeguarding the immature progenitor state. Our approach demonstrates the utility of organoid models in the identification of factors regulating cell fate and state transitions during tissue maturation and reveals that SMARCA4 and SMARCC1 prevent precocious differentiation during intestinal development.
- 14 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (28) , eadg4055
Open AccessAn organoid-based CRISPR-Cas9 screen for regulators of intestinal epithelial maturation and cell fate
Generation of functionally mature organs requires exquisite control of transcriptional programs governing cell state transitions during development. Despite advances in understanding the behavior of adult intestinal stem cells and their progeny, the transcriptional regulators that control the emergence of the mature intestinal phenotype remain largely unknown. Using mouse fetal and adult small intestinal organoids, we uncover transcriptional differences between the fetal and adult state and identify rare adult-like cells present in fetal organoids. This suggests that fetal organoids have an inherent potential to mature, which is locked by a regulatory program. By implementing a CRISPR-Cas9 screen targeting transcriptional regulators expressed in fetal organoids, we establishSmarca4andSmarcc1as important factors safeguarding the immature progenitor state. Our approach demonstrates the utility of organoid models in the identification of factors regulating cell fate and state transitions during tissue maturation and reveals that SMARCA4 and SMARCC1 prevent precocious differentiation during intestinal development.